Wikisage, the free encyclopedia of the second generation, is digital heritage

Brivaracetam: Difference between revisions

From Wikisage
Jump to navigation Jump to search
m (AED categ)
m (atc)
Line 8: Line 8:


{{Wikidata|Q408099}}
{{Wikidata|Q408099}}
===ATC===
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
|colspan=2| <center>
: [[wikipedia:brivaracetam|brivaracetam]]
<ref>http://www.whocc.no/atc_ddd_index/?code=N03AX23</ref></center>
|}


<references/>
<references/>

Revision as of 01:21, 30 March 2016

  • (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide

    (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide

4n propyl analog of levetiracetam, this a levetiracetam may have potential in the mangement of progressive myoclonic epilepsies [1]

Links

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm

Q408099 at Wikidata  Interwiki via Wikidata


ATC

brivaracetam
[2]


  1. ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/pdf/ndt-11-2967.pdf
  2. ↑ http://www.whocc.no/atc_ddd_index/?code=N03AX23
Retrieved from "https://en.wikisage.org/w/index.php?title=Brivaracetam&oldid=4206"